3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Peutz-Jeghers Syndrome
1
Pancreatitis, Chronic
1
Pancreatic Neoplasms
1
Pancreatic Cyst
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Hip Fractures
1
Glioma
1
Glioblastoma
1
Fractures, Spontaneous
1
Financial Stress
1
Dysplastic Nevus Syndrome
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
COVID-19
1
Brain Neoplasms
1
Bone Neoplasms
1
Ataxia Telangiectasia
1
Interventions
Rituximab
5
Specimen Handling
3
Cyclophosphamide
3
Biopsy
3
ibrutinib
2
fludarabine
2
binimetinib
2
Vemurafenib
2
Cladribine
2
venetoclax
1
tovorafenib
1
polatuzumab vedotin
1
pembrolizumab
1
obinutuzumab
1
immunotoxin HA22
1
fludarabine phosphate
1
encorafenib
1
brexucabtagene autoleucel
1
acalabrutinib
1
Whole-Body Irradiation
1
Transplantation
1
Tacrolimus
1
Spinal Puncture
1
Radiotherapy
1
Prednisone
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
High-Energy Shock Waves
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
Data Collection
×
90 days
×
Clear all
No trials found.